CardioNet has announced new features for its cardiac remote monitoring and diagnostic MCOT system that give physicians more in-depth data. The new features will help physicians better diagnose atrial fibrillation, heart pauses, and ventricular tachycardia.
The company stated that the new features can be used in conjunction with CardioNet's SomNet program to help identify indications of sleep...
"You can enable ubiquitous [wireless health] sensing, but without a services and disease management workflow system in place, who is this data going to?" Duke University Adjunct Associate Professor Gopal Chopra explained to Mobihealthnews in a recent interview. "Who will interpret it? If there are algorithms involved with telling users what to do, well, who is overseeing that? There's risk in...
There has been a highly speculative and questionable rumor floating around that Philips is interested in buying wireless cardiac monitoring company CardioNet. The company has had a string of bad news lately as Highmark Medicare Services officially reduced reimbursement for the company's services starting yesterday. CardioNet is also facing class action lawsuits related to the reimbursement cut....
Inc. Magazine recognized at least one wireless health-focused company as among the fastest growing companies in the U.S. by revenue. eCardio Diagnostics was ranked the 117th fastest growing company in the U.S. with $21.4 million in revenue for 2008 and three year sales growth of 1,424 percent. eCardio was the 11th fastest growing health-focused company in the country, according to the magazine....
Highmark Medicare Services (HMS) confirmed with remote monitoring service provider CardioNet that the reduced reimbursement rate for mobile cardiovascular technology will become effective today, September 1, 2009. The new rate is $754 per service and that represents a 33 percent reduction from the $1,123 reimbursement rate the service has retained all year.
"We are very disappointed at HMS'...
Wireless healthcare is, ultimately, a consumer play. That was one key message built-in to both West Wireless Health Institute's Dr. Eric Topol's presentation and CardioNet's Director of Business Development Aaron Goldmuntz's presentation this week at the Qualcomm Smart Services Leadership Summit.
There are currently 1.2 million people who use mobile fitness products to track their vital signs...
CardioNet's Director of Business Development Aaron Goldmuntz laid out his company's growth strategy during a presentation this morning at Qualcomm's Smart Services Leadership Summit here in San Diego. Immediate opportunities for growth, Goldmuntz said, included leveraging CardioNet's platform to develop additional applications that relate to atrial fibrillation. Adjacent markets could include...
As we have noted in the past, for those seeking to bring clinically-focused wireless health services to market, there are a number of trail blazers in the industry that can provide some clues for go-to-market strategies. We have discussed the FDA and FCC regulatory frameworks facing wireless health as well as the importance of securing reimbursement from (CMS) Centers for Medicare and Medicaid...
It's been a tough couple of months for wireless arrhythmia monitoring company CardioNet: The company has terminated its plans to acquire Minnesota-based Biotel, which has its own cardiac arrhythmia monitoring business, an experienced design and development team plus manufacturing capabilities that were set to support CardioNet's growing business. The deal was originally pegged at $14 million but...
After months of rumors and analyst speculation, Highmark CMS has, after all, cut the reimbursement rate for wireless cardiac monitoring MCOT services from $1,123.07 to $754. While some analysts have been anticipating a rate drop on the order of about $200 for the past few months, the rate cut was almost double that.
CardioNet, the only pure-play wireless health company that has gone public, is...
